Latest News
Sun Pharma announces US availability of UNLOXCYT (cosibelimab-ipdl) for advanced cutaneous squamous cell carcinoma
16 January 2026 - Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA, BSE:524715), an India-based specialty generic drug company, announced on Thursday that UNLOXCYT (cosibelimab-ipdl) is now available in the United States for healthcare profession...
OncoHost receives BIG Innovation Award in Health category
16 January 2026 - OncoHost, a technology company focused on precision medicine, announced on Monday that the Business Intelligence Group has named OncoHost as a winner in the 2026 BIG Innovation Awards in the Health category.Additionally, OncoHost wa...
Frontage Laboratories commences GMP facility operations
16 January 2026 - Frontage Laboratories Inc, a US-based contract development and manufacturing organisation (CDMO) and subsidiary of Frontage Holdings Corporation (HKEX:1521), announced on Thursday that it has commenced operations at its GMP facility...
Hoth Therapeutics achieves European regulatory milestone for HT-001
16 January 2026 - Hoth Therapeutics Inc (NASDAQ:HOTH), a US-based clinical-stage biopharmaceutical company, announced on Thursday that it has achieved a major European regulatory milestone for its HT-001 clinical programme, targeting cancer patients ...
Zydus Lifesciences acquires Agenus Inc's biologics manufacturing facilities, launches Zylidac Bio LLC in US
16 January 2026 - Zydus Lifesciences Limited, an India-based life-sciences company, announced on Thursday that it has completed an Asset Purchase Agreement, Share Purchase Agreement, and exclusive Licensing Agreement with Agenus Inc (NASDAQ:AGEN), a ...